CVE-2023-20229

CVE-2023-20229 is a high-severity vulnerability in Cisco Duo Device Health Application with a CVSS 3.x base score of 7.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Description

A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks and overwrite arbitrary files on an affected system. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by executing a directory traversal attack on an affected host. A successful exploit could allow an attacker to use a cryptographic key to overwrite arbitrary files with SYSTEM-level privileges, resulting in a denial of service (DoS) condition or data loss on the affected system.

Frequently asked questions

What is CVE-2023-20229?
A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks and overwrite arbitrary files on an affected system. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by executing a directory traversal attack on an affected host. A successful exploit could allow an attacker to use a cryptographic key to overwrite arbitrary files with SYSTEM-level privileges, resulting in a denial of service (DoS) condition or data loss on the affected system.
How severe is CVE-2023-20229?
CVE-2023-20229 has a CVSS 3.x base score of 7.1, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability high.
Is CVE-2023-20229 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (31st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-20229?
CVE-2023-20229 affects Cisco Duo Device Health Application. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-20229?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-20229 published?
CVE-2023-20229 was published on 2023-08-16 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-22 (Path Traversal) vulnerabilities

Browse all CWE-22 (Path Traversal) vulnerabilities →